Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2021-05-20
2026-05-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Hip Flexors Isokinetic Strengthening on Gait Capacities in Subacute Stroke Patients
NCT02917850
Strengthening in Sub-acute Stroke Survivors: A Randomized Controlled Trial
NCT06140381
Dose-Finding of Lower Limb Mirror Therapy After Stroke.
NCT04339803
Muscular Strengthening for Paretic Knee Flexor and Extensor by Conventional Physiotherapy on Chronic Hemiplegic Stroke Patients
NCT00570570
The Effects of Plantar Flexion Training in People With Chronic Stroke
NCT03548090
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The patients will be recruited in 5 centers during their hospitalization, in sub-acute phase. Two groups will be formed: a control group in conventional rehabilitation; an experimental group that will perform 5x/week 300 movements of plantarflexion, dorsiflexion on isokinetic dynamometer (in passive mode, with the intention of producing the greatest possible force). This protocol will take place over 6 weeks.
Follow-up visits will take place at the end of the 6th week (which corresponds to the end of the ankle rehabilitation protocol), 6 months and one year after the beginning of the protocol.
These visits will include a clinical examination, a GaitRite carpet walking test, an isokinetic evaluation of the ankle dorsiflexor muscles strength and a SIPSO self-administered questionnaire (social participation) at 6 months and one year.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
Rehabilitation program 1
Both groups will benefit from a conventional rehabilitation treatment including a repetitive walking.
In addition to this conventional rehabilitation, the experimental group will receive an ankle isokinetic program, 5 times a week, for 6 weeks (with a minimum of 25 sessions)
Control group
Rehabilitation program 2
Both groups will benefit from a conventional rehabilitation treatment including a repetitive walking.
The control group will have a supplement in conventional rehabilitation equal to the additional time of the experimental group.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rehabilitation program 1
Both groups will benefit from a conventional rehabilitation treatment including a repetitive walking.
In addition to this conventional rehabilitation, the experimental group will receive an ankle isokinetic program, 5 times a week, for 6 weeks (with a minimum of 25 sessions)
Rehabilitation program 2
Both groups will benefit from a conventional rehabilitation treatment including a repetitive walking.
The control group will have a supplement in conventional rehabilitation equal to the additional time of the experimental group.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ischemic or hemorrhagic stroke hospitalized in MPR in sub-acute phase (15 days to 3 months)
* Persistent deficiency of foot lifts (Medical Research Council testing: MRC \<5)
* Walking alone at least 10 meters with or without technical assistance
* Absence of pain in the lower limb (EVA \<2)
Exclusion Criteria
* Gait disorder before stroke
* Fixed stiffness of the ankle (irreducible equine less than 30 °)
* Spasticity too important: Modified Ashworth (MAS) greater than or equal to 4.
* Pregnancy or desire for pregnancy, breastfeeding
* Patient under curatorship or guardianship or under the protection of justice
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Limoges
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Christophe DAVIET
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Limoges
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Reeducation Institute Les Embruns
Bidart, , France
University Hospital
Bordeaux, , France
DUBOIS Hospital
Brive-la-Gaillarde, , France
University Hospital
Limoges, , France
University Institute of Rehabilitation Valmante Sud
Marseille, , France
Functional rehabilitation center
Noth, , France
University Hospital
Poitiers, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Ferry B, Compagnat M, Yonneau J, Bensoussan L, Moucheboeuf G, Muller F, Laborde B, Jossart A, David R, Magne J, Marais L, Daviet JC. Awakening the control of the ankle dorsiflexors in the post-stroke hemiplegic subject to improve walking activity and social participation: the WAKE (Walking Ankle isoKinetic Exercise) randomised, controlled trial. Trials. 2022 Aug 16;23(1):661. doi: 10.1186/s13063-022-06545-w.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
87RI20_0010 (WAKE)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.